Steven T Thornton Net Worth & Insider Trades
Steven T Thornton - Director, Halozyme Therapeutics Inc
What is Steven T Thornton's Net Worth?
The current estimated net worth of Halozyme Therapeutics Inc's Director, Steven T Thornton, is estimated to be about $966.47K . Steven T Thornton owns about 15,000 units of Halozyme Therapeutics Inc common stock. In the last year at Halozyme Therapeutics Inc, Steven T Thornton has sold an estimated value of $414.96K worth.
What is Steven T Thornton's Past Insider Trading?
Steven T Thornton's largest purchase order was 10,000 units , worth over $28K on June 15, 2007. Steven T Thornton's largest sale order was 30,000 units , worth over $314.72K on May 22, 2007. In total, Steven T Thornton has made about 3 transactions over a year of their time at Halozyme Therapeutics Inc. Steven T Thornton usually trades in May, with the busiest year in 2007.
Steven T Thornton
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Steven T Thornton's' Mailing Address?
- Mailing address is 11588 Sorrento Valley Road, Suite 17 San Diego CA 92121 CA
Halozyme Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Helen I. Torley | 2020 | $791,440 | - | $2,500,018 | $2,500,001 | $712,270 | $15,147 | $6,518,876 |
| Helen I. Torley | 2019 | $761,000 | - | $2,184,130 | $2,184,128 | $712,296 | $15,572 | $5,857,126 |
| Helen I. Torley | 2018 | $725,000 | - | $2,115,640 | $2,115,631 | $831,665 | $11,733 | $5,799,669 |
| Elaine D. Sun | 2020 | $395,833 | $150,000 | $1,500,269 | $1,000,008 | $180,352 | $133,399 | $3,359,861 |
| Laurie D. Stelzer | 2020 | $93,225 | - | - | - | - | $77,996 | $171,221 |
| Laurie D. Stelzer | 2019 | $495,000 | $2,500 | $750,016 | $750,005 | $231,660 | $16,939 | $2,246,120 |
| Laurie D. Stelzer | 2018 | $470,000 | - | $575,018 | $575,009 | $323,489 | $9,409 | $1,952,925 |
| Masaru Matsuda | 2020 | $440,000 | $50,000 | $500,019 | $500,008 | $203,940 | $13,901 | $1,707,868 |
| Michael J. LaBarre | 2020 | $475,000 | - | $650,009 | $650,007 | $220,163 | $15,018 | $2,010,197 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm
What are Halozyme Therapeutics Inc's Past Insider Trades?
Halozyme Therapeutics Inc's most recent insider trade came on April 19, 2023 by Michael Labarre who sold 10,000 units worth $360K . In the last 16 years, insiders at Halozyme Therapeutics Inc have sold an estimated value of $148.57M and bought an estimated value of $83.67M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO, Gregory Ian Frost, CEO, and Michael Labarre, SVP .
HALOZYME THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||